Persistence of skin contamination & environmental shedding of Clostridium difficile
"Persistence of skin contamination & environmental shedding of Clostridium difficile during and after treatment of C. difficile infection"
Infect Control Hosp Epidemiol. 2010 Jan
Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ.
Department of Epidemiology and Biostatistics, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland
BACKGROUND :: Current guidelines for control of Clostridium difficile infection (CDI) suggest that contact precautions be discontinued after diarrhea resolves. However, limited information is available regarding the frequency of skin contamination and environmental shedding of C. difficile during and after treatment.
DESIGN :: We conducted a 9-month prospective, observational study involving 52 patients receiving therapy for CDI. Stool samples, skin (chest and abdomen) samples, and samples from environmental sites were cultured for C. difficile before, during, and after treatment. Polymerase chain reaction ribotyping was performed to determine the relatedness of stool, skin, and environmental isolates.
RESULTS :: Fifty-two patients with CDI were studied. C. difficile was suppressed to undetectable levels in stool samples from most patients during treatment; however, 1-4 weeks after treatment, 56% of patients who had samples tested were asymptomatic carriers of C. difficile. The frequencies of skin contamination and environmental shedding remained high at the time of resolution of diarrhea (60% and 37%, respectively), were lower at the end of treatment (32% and 14%, respectively), and again increased 1-4 weeks after treatment (58% and 50%, respectively). Skin and environmental contamination after treatment was associated with use of antibiotics for non-CDI indications. Ninety-four percent of skin isolates and 82% of environmental isolates were genetically identical to concurrent stool isolates.
CONCLUSIONS :: Skin contamination and environmental shedding of C. difficile often persist at the time of resolution of diarrhea, and recurrent shedding is common 1-4 weeks after therapy. These results provide support for the recommendation that contact precautions be continued until hospital discharge if rates of CDI remain high despite implementation of standard infection-control measures.
- Division Chief Message
- Past Year in Review
- Penicillin sulfone inhibitors of class D beta-lactamases
- In vitro activity of penem-1 in combination with beta-lactams against blaKPC-possessing Klebsiella pneumoniae isolates.
- Evaluation of an alcohol-based power sanitizing system
- Saline Nebulization before Gastric Lavage in the Diagnosis of Pulmonary Tuberculosis in Children and Adolescents
- Preserved MHC class II antigen processing in monocytes from HIV-infected individuals
- Acinetobacter baumannii-associated skin and soft tissue infections
- Streptococcus anginosus Pyomyositis in a 50-Year-Old Man with Acquired Immunodeficiency Syndrome
- Antibiotic resistance determinants in Acinetobacter spp and clinical outcomes
- Influenza-Induced Production of Interferon-Alpha is Defective in Geriatric Individuals
- Enhancing resistance to cephalosporins in class C beta-lactamases
- Three decades of beta-lactamase inhibitors
- In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates
- Persistence of skin contamination & environmental shedding of Clostridium difficile
- Comparative description of haplotype structure and genetic diversity of MDR1
- Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design
- Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase
- Increased tissue factor expression on circulating monocytes in chronic HIV infection
- The Fight Against TB
- Patient Care
- Fellowship Program